New breast implant for patients undergoing breast reconstruction, augmentation or revision surgery
MENTOR ® Announces U.S. Availability For MemoryGel® Xtra Breast Implants
AbstractBackgroundAugmentation mammoplasty is one of the most common esthetic procedures worldwide. A wide range of motivations leads women to undergo this procedure, among them socioeconomic status and age group. The aim of this study was to identify the motivation spectrum for augmentation mammoplasty through different age groups.MethodsWe conducted a cross-sectional prospective survey given to Israeli women seeking augmentation mammoplasty consults in a hospital and private clinic settings, using a 17-item Motivation for Augmentation questionnaire. Three motivation domains were examined: appearance, sexuality and social...
I want to get a breast augmentation done and the doctor says I should take a week off from work to recover. Am I able to pre-plan "sick days" in advance at CVS? I don't want to use my vacation days if possible.
Poly Implant Proth èse (PIP) was a company that manufactured substandard breast implants using cheaper non-medical grade silicon. Around 40,000 women in the UK are thought to have PIP implants inserted(1). The advice for Women in Wales is: seek clinical advice prior to requesting routine removal. If there is clinical need, the National Health Service (NHS) in Wales funds removal and replacement of PIP breast implants inserted privately. This is in contrast to NHS in England where only PIP implants placed on the NHS are replaced.
New publication adds to substantial clinical data demonstrating safety and effectiveness of MENTOR® Breast Implants in primary and revision augmentation and reconstruction patients IRVINE, Calif., Feb. 14, 2018 -- (Healthcare Sales &Marketing Netwo... Devices Mentor Worldwide, Johnson &Johnson , MENTOR , MemoryShape, breast implant
Breast implant-associated anaplastic large cell lymphoma (BI-ALCL) is a rare T-cell lymphoma that arises around breast implants. Most patients manifest with periprosthetic effusion, whereas a subset of patients develops a tumor mass or lymph node involvement (LNI). The aim of this study is to describe the pathologic features of lymph nodes from patients with BI-ALCL and assess the prognostic impact of LNI. Clinical findings and histopathologic features of lymph nodes were assessed in 70 patients with BI-ALCL. LNI was defined by the histologic demonstration of ALCL in lymph nodes. Fourteen (20%) patients with BI-ALCL had LN...
ConclusionsThe epidemiology of the disease strongly suggests that the vast majority of cases are not a cancer that will inevitably progress without treatment. The findings presented in the manuscript provide supportive clinical evidence. Consequently, an alternative view of BIA-ALCL with implications for research, diagnosis and clinical management needs to be considered.Level of Evidence IVThis journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authorswww.springer.com/00266.
DALLAS - A Texas federal judge on Jan. 26 dismissed the remaining discrimination claim in a disability claimant's suit seeking benefits under a short-term disability (STD) plan for breast augmentation surgery to treat the illness of gender dysphoria after determining that the claimant failed to prove that the employer discriminated against her under Title VII of the Civil Rights Act (Charlize Marie Baker v. Aetna Life Insurance Co., et al., No. 15-3679, N.D. Texas; 2018 U.S. Dist. LEXIS 12854).
Conclusions: This study is one of the first to suggest an innovative approach for explaining the positional relationships between the PM and EAO. Our findings can be useful for surgeons attempting to produce optimal outcomes in DPBA, especially in procedures that involve patients of different races. This article is protected by copyright. All rights reserved.